AMC 095 (AIDS Malignancy Consortium): A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV associated solid tumors (ST) with expansion cohorts in HIV associated solid tumors and classical Hodgkin lymphoma (cHL).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, University of Arkansas for Medical Sciences, National Cancer Institute, University of North Carolina at Chapel Hill, Albert Einstein College of Medicine, Morristown Medical Center, Atlantic Health System, University of California, Los Angeles
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4236284945